XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Description of Business and Organization - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Jun. 01, 2021
May 23, 2021
Jun. 30, 2021
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Dec. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Line Items]              
Proceeds from issuance of initial public offering $ 167,000            
Payments of stock issuance costs $ 17,000            
Share-based compensation arrangement by share-based payment award, options, vested, number of shares       4,719,605      
Common stock shares authorized       500,000,000 500,000,000    
Preferred stock shares authorized       10,000,000      
Common stock par or stated value per share       $ 0.0001 $ 0.0001    
Preferred stock par or stated value per share       $ 0.0001      
Stockholders' equity note, stock split   2.325-for-1          
Retained Earnings (Accumulated Deficit)       $ (155,234) $ (127,487)    
Cash and cash equivalents       $ 262,731 $ 284,309 $ 154,870 $ 43,728
IPO [Member]              
Organization Consolidation And Presentation Of Financial Statements [Line Items]              
Common stock issued in IPO, net of issuance costs of $16,995 (In shares) 11,500,000   11,500,000        
Shares issued, price per share $ 16.00     $ 16.00      
Number of shares issued upon conversion       5,433,290      
Stock issued during period, shares, conversion of units       32,489,398      
Share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures       4,418,874      
Over-Allotment Option [Member]              
Organization Consolidation And Presentation Of Financial Statements [Line Items]              
Stock issued during period, shares, issued for services 1,500,000            
Series A Redeemable Convertible Preferred Stock [Member]              
Organization Consolidation And Presentation Of Financial Statements [Line Items]              
Common stock par or stated value per share       $ 0.0001      
Series A Redeemable Convertible Preferred Stock [Member] | Millennium Pharmaceuticals, Inc. [Member] | The Millennium Stock Exchange Agreement [Member]              
Organization Consolidation And Presentation Of Financial Statements [Line Items]              
Conversion of stock, shares converted       9,857,143      
Convertible preferred stock, shares issued upon conversion       6,470,382